August 12th, 2025
10:00 AM PT
From lab to commercialization: Navigate the evolving risks of life science companies
Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding international clinical trial requirements and adapting to the rise of AI in research and product development.
In this three-part webinar series, our experts will help you identify critical insurance considerations and risk mitigation strategies at every stage of your company’s growth. Each session is designed to address a distinct challenge in the life science ecosystem—whether you're moving toward clinical trials, preparing for an IPO, or integrating AI technologies.
We’ll break down:
- Essential coverages by growth stage
- Country-specific clinical trial requirements
- Real-world risks and insurance implications of AI in life sciences
Whether you’re an early-stage biotech company or preparing for commercialization, join us to gain actionable insights and stay ahead in this dynamic industry.
Webinar 3
International Clinical Trials Country Requirements- What You Need To Know
Join us for an insightful webinar that recaps the phases of clinical trials from I to IV and delves into the latest updates on international clinical trial country requirements. Learn what to expect when securing coverage for your trial within different countries and stay ahead of the curve in clinical research.
